ABBV vs DD · P/E 81, rev $61.16B vs P/E 127, rev $12.39B
AbbVie Inc (ABBV) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ABBV and DD stock pages for the full models.
Not investment advice.